Markedly reduced rate of diabetic ketoacidosis at onset of type 1 diabetes in relatives screened for islet autoantibodies

Pediatric Diabetes

Volumn 13, Issue 4, 2012, Pages 308-313

  Winkler, Christiane ^a   Schober, Edith ^b   Ziegler, Anette Gabriele ^a,c   Holl, Reinhard W ^d  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; GLUCOSE; HEMOGLOBIN A1C; INSULIN; PANCREAS ISLET BETA CELL AUTOANTIBODY; UNCLASSIFIED DRUG; GLYCOSYLATED HEMOGLOBIN;

ANTIBODY SCREENING; ARTICLE; BLOOD PH; CHILD; CONTROLLED STUDY; DIABETIC KETOACIDOSIS; DISEASE COURSE; DISEASE DURATION; DISEASE REGISTRY; FAMILY HISTORY; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HIGH RISK POPULATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RELATIVE; RISK ASSESSMENT; ADOLESCENT; GERMANY; IMMUNOLOGY; METABOLISM; PANCREAS ISLET;

ADOLESCENT; AUTOANTIBODIES; BLOOD GLUCOSE; CHILD; DIABETES MELLITUS, TYPE 1; DIABETIC KETOACIDOSIS; FEMALE; GERMANY; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN; ISLETS OF LANGERHANS; MALE;

EID: 84861711458     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/j.1399-5448.2011.00829.x     Document Type: Article

References (23)

1. Patterson CC, Dahlquist GG, Gyurus E, Green A, Soltesz G. Incidence trends for childhood type 1 diabetesin Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study. Lancet 2009: 373: 2027-2033.
2. Ziegler AG, Nepom GT. Prediction and pathogenesis in type 1 diabetes. Immunity 2010: 32: 468-478.
3. Achenbach P, Bonifacio E, Ziegler AG. Predicting type 1 diabetes. Curr Diab Rep 2005: 5: 98-103.
4. Bingley PJ, Gale EA. Progression to type 1 diabetesin islet cell antibody-positive relatives in the European Nicotinamide Diabetes Intervention Trial: the role of additional immune, genetic and metabolic markers of risk. Diabetologia 2006: 49: 881-890.
5. Achenbach P, Lampasona V, Landherr U et al. Autoantibodies to zinc transporter 8 and SLC30A8 genotype stratify type 1 diabetes risk. Diabetologia 2009: 52: 1881-1888.
6. Ziegler AG, Hummel M, Schenker M, Bonifacio E. Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: the 2-year analysis of the German BABYDIAB Study. Diabetes 1999: 48: 460-468.
7. Barker JM, Barriga KJ, Yu L et al. Prediction of autoantibody positivity and progression to type 1 diabetes: Diabetes Autoimmunity Study in the Young (DAISY). J Clin Endocrinol Metab 2004: 89: 3896-3902.
8. TEDDY Study Group. The Environmental Determinants of Diabetes in the Young (TEDDY) study: study design. Pediatr Diabetes 2007: 8: 286-298.
9. Barker JM, Goehrig SH, Barriga K et al. Clinical characteristics of children diagnosed with type 1 diabetes through intensive screening and follow-up. Diabetes Care 2004: 27: 1399-1404.
10. Neu A, Hofer SE, Karges B et al. German BMBF Competency Network for Diabetes Mellitus. Ketoacidosis at diabetes onset is still frequent in children and adolescents: a multicenter analysis of 14, 664 patients from 106 institutions. Diabetes Care 2009: 32: 1647-1648.
11. Galler A, Stange T, Müller G et al. Incidence of childhood diabetes in children aged less than 15 years and its clinical and metabolic characteristics at the time of diagnosis: data from the childhood diabetes registry of Saxony, Germany. Horm Res Paediatr 2010: 74: 285-291.
12. Dittler J, Seidel D, Schenker M, Ziegler AG. GADIA2-combi determination as first-line screening for improved prediction of type 1 diabetes in relatives. Diabetes 1998: 47: 592-597.
13. Grabert M, Schweiggert F, Holl RW. A framework for diabetes documentation and quality management in Germany: 10 years of experience with DPV. Comput Methods Programs Biomed 2002: 69: 115-121.
14. Puavilai G, Chanprasertyotin S, Sriphrapradaeng A. Diagnostic criteria for diabetes mellitus and other categories of glucose intolerance: 1997 criteria by the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (ADA), 1998 WHO consultation criteria, and 1985 WHO criteria. World Health Organization. Diabetes Res Clin Pract 1999: 44: 21-26.
15. Rohrer TR, Hennes P, Thon A et al. Down's syndrome in diabetic patients younger than 20 years: an analysis of metabolic status, glycaemic control and autoimmunity in comparison with type 1 diabetes. Diabetologia 2010: 53: 1070-1075.
16. du Prel JB, Icks A, Grabert M, Holl RW, Giani G, Rosenbauer J. Socioeconomic conditions and type 1 diabetes in childhood in North Rhine-Westphalia, Germany. Diabetologia 2007: 50: 720-728.
17. Schober E, Rami B, Waldhoer T. Austrian Diabetes Incidence Study Group. Diabetic ketoacidosis at diagnosis in Austrian children in 1989-2008: a population-based analysis. Diabetologia 2010: 53: 1057-1061.
18. Galatzer A, Green E, Ofan R et al. Psychological impact of islet cell antibody screening. J Pediatr Endocrinol Metab 2001: 14 (Suppl. 1): 675-679.
19. Johnson BS, Tercyak KP Jr. Psychological impact of islet cell antibody screening for IDDM on children, adults, and their family members. Diabetes Care 1995: 18: 1370-1372.
20. Komulainen J, Lounamaa R, Knip M, Kaprio EA, Akerblom HK. Ketoacidosis at the diagnosis of type 1 (insulin dependent) diabetes mellitus is related to poor residual beta cell function. Childhood Diabetes in Finland Study Group. Arch Dis Child 1996: 75: 410-415.
21. Hummel M, Ziegler AG, Roth R. Psychological impact of childhood islet autoantibody testing in families participating in the BABYDIAB study. Diabet Med 2004: 21: 324-328.
22. Vanelli M, Chiari G, Costi G, Ghizzoni L, Giacalone T, Chiarelli F. Effectiveness of a prevention program for diabetic ketoacidosis in children. Diabetes Care 1999: 22: 7-9.
23. Hekkala A, Knip M, Veijola R. Ketoacidosis at diagnosis of type 1 diabetes in children in Nothern Finland. Diabetes Care 2007: 30: 861-866.